Dr Lee Kim Shang
Senior Consultant
Specialty Radiation Oncology
Phone +65 6731 2781
Fax +65 6731 2411
Email kimshang.lee@ihhhealthcare.com
Qualifications

MBBS (Singapore), FRCR (Clinical Oncology), FAMS (Radiation Oncology)

Languages Spoken Cantonese, English, Hokkien, Mandarin
Make An Appointment

Clinic Address(es)

3 Mount Elizabeth
Mount Elizabeth Hospital
Level 2
Radiation Oncology Centre,

Singapore 228510

6A Napier Road
Gleneagles Hospital Level 1
Radiation Oncology Centre,
Singapore 258500

Tel: +65 6470 5830

38 Irrawaddy Road
Mount Elizabeth Novena
Hospital Basement 1
Radiation Oncology Centre,
Singapore 329563

Tel: +65 6933 0128

38 Irrawaddy Road,
Mount Elizabeth Novena
Hospital Basement 2
Proton Therapy Centre
Singapore 329563
Tel: +65 6933 0211
Email: protontherapy@ihhhealthcare.com

Profile

Dr Lee Kim Shang is a Senior Consultant, Radiation Oncologist at Parkway Cancer Centre.

Dr Lee Kim Shang graduated from the National University of Singapore in 1985. He received the Ministry of Health HMDP Fellowship to train in Saint Bartholomew’s Hospital in London from 1990 to 1992, and at the Neuro-Oncology Unit, Royal Marsden Hospital, United Kingdom in 1996. Dr Lee received his FRCR (Clinical Oncology) in 1993.

Prior to joining Parkway Pantai Hospitals (Singapore) as a senior consultant, Dr Lee Kim Shang was appointed as a Senior Consultant, Therapeutic Radiology Department at National Cancer Centre where he was also the Department Subspecialty Head for colorectal cancer at National Cancer Centre. During that time, Dr Lee Kim Shang held numerous concurrent appointments including Chairman of the Therapeutic Radiology Department Safety Committee, member of Ministry of Health Colorectal Cancer Clinical Practice Guidelines Committee and member of the Specialist Training Committee (Radiation Oncology) in the Ministry of Health. Currently, he is also a member of the Proton Beam Therapy Advisory Committee of the Ministry of Health.

Apart from general oncology, Dr Lee Kim Shang has an interest in colorectal, central nervous, breast and paediatric cancers.